PharmiWeb.com - Global Pharma News & Resources

Company Directory

PharmiWeb's Pharma Company Directory is a comprehensive and searchable listing of organisations within the Pharma, Biotech & Life Sciences sector. Use it to find partner organisations, suppliers, or even a company to work for!

As an organisation, a basic listing is FREE, and can raise your profile in the industry, making you visible to thousands of monthly site visitors.

To add your organisation to the directory, simply register as a contributor and add your organisation's details. 

Note that we only accept contributions relating to the Pharma industry and that it will typically take 2 working days to approve (or otherwise) your details. Once approved, you will also be able to contribute press releases and event details to our site. Our desision is final.

Create a free account to list your company for free!

EMOTIV is a bioinformatics company advancing understanding of the human brain using electroencephalography (EEG). Our mission is to empower individuals to understand their own brain and accelerate brain research globally. Founded in 2011 by tech entrepreneurs Tan Le (CEO) and Dr. Geoff Mackellar (CTO), the company is headquartered in San Francisco, U.S.A. with facilities in Sydney, Hanoi and Ho Chi Minh City. The technology falls under the umbrella of BCIs (Brain Computer Interface) also referred to as MMI (Mind Machine Interface), DNI (Direct Neural Interface), BMI (Brain Machine Interface) and aims to track cognitive performance, monitor emotions, and control both virtual and physical objects via machine learning of trained mental commands.
A global, independent, full-service agency in medical communications. We help clients Metamorph™ Science into Action that changes healthcare so improving the lives of patients. We have helped clients achieve their goals since 2007 with impactful strategy, creative content, innovative digital and emotive design.
Enara Bio™ (formerly known as Ervaxx) is a science-led company targeting the T-cell/cancer cell interface (the “immune synapse”) to develop new targeted cancer immunotherapies designed to treat a broad patient population.
We are fully equipped and well-positioned to realize the potential of Encoded’s novel approach to gene therapy for people living with pediatric central nervous system (CNS) diseases and their families.
Our mission is to identify novel drug targets and effective therapeutics for fibrosis and solid tumours by testing cells in their natural microenvironment using our pioneering human extracellular matrix platform.
Enterome is a clinical stage biopharmaceutical company developing novel therapeutics based on its unique ability to de-code molecular interactions in the gut microbiome impacting human health.
We revolutionize the way of cancer diagnostics using our unique, proprietary DNA methylation biomarker technology. Epigenomics develops and commercializes patient-friendly, blood-based diagnostic tests across multiple cancer indications with high medical need.
Epithelix Sàrl provides alternative in vitro solutions to animal experimentation for evaluating the effects of drugs in development and assess the toxicity of chemical compounds on the human respiratory tract. Epithelix is a biotech company founded in March 2006 and located in Geneva, Switzerland.
Epworth HealthCare is Victoria’s largest not-for-profit private hospital group, renowned for excellence in diagnosis, treatment, care and rehabilitation. Epworth is an innovator in Australia’s health system, embracing the latest in evidence-based medicine to pioneer treatments and services for our patients.
Ethypharm is a specialty pharmaceutical company with prominent products in targeted central nervous system (CNS) indications, notably severe pain, and opioid dependency as well as a wide range of high-quality injectable medicines for critical care situations.
The vision of EPSA is to represent, reach and engage every single pharmaceutical student in Europe by bringing pharmacy, knowledge and students together while promoting professional development. EPSA was established in 1978 and represents over 100,000 pharmaceutical students across 37 European countries.
Evestia Clinical is a leading CRO specializing in clinical trials for oncology and rare diseases. With a commitment to scientific excellence, innovation, and patient-centric research, Evestia Clinical partners with biotech companies to accelerate the development of lifesaving therapies. Backed by Kester Capital, Evestia Clinical is dedicated to advancing healthcare through cutting-edge clinical research. Evestia Clinical’s vision is to be the market-leading clinical service partner for biotechs and beyond - fuelling medical breakthroughs to improve global health within a culture that values, inspires, and empowers.